Some six million people who are eligible for a third dose of the COVID vaccine in England are yet to have one.
Some six million people who are eligible for a third dose of the COVID vaccine in England are yet to have one.
At 11:00 am ET today (November 2, 2021), the results will be released for research that analyzed the effectiveness of the Johnson...
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers,...
In focusing on the stories of recovery this documentary, following patients participating in stem cell research trials in the...
A new study adds to the evidence that chemotherapy enhances cancer's spread beyond the primary tumor, showing how one chemo drug...
Booster shots aim to bolster waning COVID-19 immunity over time. Although U.S. public health authorities are considering a change...
According to a new study, distinct information about familiar faces is encoded in a neural code that is shared across brains.
Weight loss after gestational diabetes can prevent the onset of type 2 diabetes. Yet finding the most effective way to lose weight...
One quarter of stillbirths could have been avoided, U.K. study finds